Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now
Close

AstraZeneca PLC ADR (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AstraZeneca ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
64.19 +0.09    +0.13%
11:46:49 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 3,577,302
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 63.26 - 64.25
AstraZeneca ADR 64.19 +0.09 +0.13%

AstraZeneca PLC ADR Company Profile

 
Get an in-depth profile of AstraZeneca PLC ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

83500

Equity Type

ADR

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company’s marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Contact Information

Address 1 Francis Crick Avenue Cambridge Biomedical Campus
Cambridge, CB2 0AA
United Kingdom
Phone 44 20 3749 5000
Fax -

Top Executives

Name Age Since Title
Pascal Soriot 62 2012 CEO & Executive Director
Philip Arthur John Broadley 62 2017 Senior Independent Non-Executive Director
Marcus Wallenberg 67 1999 Non-Executive Director
Deborah DiSanzo Eldracher 63 2017 Independent Non-Executive Director
Shu Kam Mok 61 2019 Independent Non-Executive Director
Nazneen Rahman 55 2017 Independent Non-Executive Director
Rain Henderson - - Member of External Sustainability Advisory Board
Diana Layfield 51 2020 Independent Non-Executive Director
Sherilyn S. D. McCoy 64 2017 Independent Non-Executive Director
Pankaj Bhatia - - Member of External Sustainability Advisory Board
Michel Demare 67 2019 Independent Chairman
Polly Courtice 71 - Member of External Sustainability Advisory Board
Louise Nicholls - - Member of External Sustainability Advisory Board
Euan A. Ashley 51 2020 Independent Non-Executive Director
Andreas Rummelt 67 2021 Independent Non-Executive Director
Anna Olive Magdelene Manz 50 2023 Non-Executive Director
Jeffrey Pott - 2009 CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board
Pam P. Cheng 52 2015 EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board
Menelas Pangalos 56 2013 EVP of BioPharmaceuticals R&D and Member of External Sustainability Advisory Board
Aradhana Sarin 48 2021 CFO & Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dennis Wiseman
Dennis Wiseman Feb 07, 2024 10:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
stron bullish sentiment. buy in don't miss out
Luis Anderson
Luis Anderson Nov 27, 2023 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
upside channel.... time to buy
sohan kumar paswan
sohan kumar paswan Oct 27, 2023 12:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
see all my view dep 14♥️
Sawlaram Choudhary
Sawlaram Choudhary Oct 17, 2023 3:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
See all my view sep 14
Sawlaram Choudhary
Sawlaram Choudhary Sep 14, 2023 2:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zoom fire rocket share now 70+ in few Days only.
Sawlaram Choudhary
Sawlaram Choudhary Sep 13, 2023 1:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target 69 this month.
Andre Van Laer
Andre Van Laer Mar 23, 2023 2:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why would anyone buy this thing...?
Neek Kajula
Neek Kajula Mar 24, 2022 9:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
did they develop a vaccine that works now or why is thos going up?
Hold This Sheet
Hold This Sheet Sep 23, 2021 2:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Valneva
damian del
mudlog79 Sep 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why this trash going up?
Pascal Torres
Pascal Torres Sep 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
speculation
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email